08:07 AM EST, 12/10/2025 (MT Newswires) -- STAAR Surgical ( STAA ) shareholder Yunqi Capital said Wednesday that it is opposed to the company's acquisition by Alcon ( ALC ) , saying that it is not the right time to sell.

The investment firm, which owns 5.1% of the company, said that even with the revised offer of $30.75 per share, it is against the transaction, and that it believes STAAR Surgical ( STAA ) "has mismanaged its attempt to sell the company from the start."

Yunqi Capital said the go-shop process was conducted to "seal the Alcon ( ALC ) deal," rather than seek other bidders and that STAAR "has not been fully transparent with shareholders" about the proposed acquisition.

STAAR Surgical ( STAA ) did not immediately respond to a request for comment from MT Newswires.

STAAR Surgical ( STAA ) shares were more than 5% lower in premarket trading, while Alcon ( ALC ) was 0.7% higher.